Chargement en cours...
An argument for broad use of high efficacy treatments in early multiple sclerosis
Two different treatment paradigms are most often used in multiple sclerosis (MS). An escalation or induction approach is considered when treating a patient early in the disease course. An escalator prioritizes safety, whereas an inducer would favor efficacy. Our understanding of MS pathophysiology h...
Enregistré dans:
| Publié dans: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935832/ https://ncbi.nlm.nih.gov/pubmed/31757815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000636 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|